US stocks look constructive into year-end at the index level — but published research is split hard on AI names, with several warnings of a multi-year AI-led drawdown ahead.
The bull case leans on seasonality (late-October lows, midterm-year rallies, year-end push) plus a strong Q3 earnings season with roughly 83% of companies beating. One camp of analysts argues the correction that began in June is 80-90% done, with the S&P multiple compressed from about 23x to 18-19x, and flags 7,605 as a key level. Researchers favoring US exposure point to earnings growth and AI capex, though a contrarian thread sees the defensive rotation as already stretched.
Under the hood, the debate is growth vs value. Some recently published views expect growth leadership to return if big-tech earnings hold, with constructive mentions of Alphabet and Meta — but only for hyperscalers showing real demand, monetization and free-cash-flow upgrades. On sectors, healthcare splits opinion: preferred by some over financials into the midterms, viewed as overbought by others. Energy is seen as exposed if an Iran deal lands.
On AI risk, multiple research notes flag corrections ranging from 10-15% to full bubble-burst scenarios, placed 18 months to three years out, with 2027 cited as a downside window. A rumored Anthropic listing near a $1.5 trillion valuation is drawing broad caution. NVIDIA is the clearest fault line — near-term bullish in some notes, structurally bearish from 2027 in others.
By the numbers:
• Positioning (CFTC, as of 20 Oct 2026): Speculators (leveraged funds) are net long Nasdaq-100 (E-mini) and net short S&P 500 (E-mini) and Russell 2000 (E-mini). S&P 500 (E-mini) (51) and Russell 2000 (E-mini) (59) are mid-range; Nasdaq-100 (E-mini) (84) is near the top of its 52-week range.